Sector revisions Nipro Corporation

Stocks

Market Closed - Japan Exchange 09:30:00 11/09/2026 +03			5-day change	1st Jan Change
1,438.50 ^JPY	-0.52%		-2.14%	-2.61%

07-30	Nipro Corporation Receives Fda 510(K) Clearance for Elisio-Hx Dialyzer and Introduces Hds to the United States	CI
07-29	Vat Holding AG agreed to acquire 100% stake in Atonarp Inc. from Nipro Corporation for CHF 110 million.	CI

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	NIPRO CORPORATION							5
	ABBOTT LABORATORIES							25
	MEDTRONIC PLC							25
	CENCORA, INC.							13
	HOYA CORPORATION							15
	BECTON, DICKINSON AND COMPANY							12
	DEXCOM, INC.							25
	MEDLINE INC.							25
	WEST PHARMACEUTICAL SERVICES, INC.							16
	TERUMO CORPORATION							13
	SARTORIUS STEDIM BIOTECH							14
	STERIS PLC							8
	ZIMMER BIOMET HOLDINGS, INC.							21
	SOLVENTUM CORPORATION							13
	FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED							11
	BAXTER INTERNATIONAL INC.							11
	ALIGN TECHNOLOGY, INC.							15
	AVANTOR, INC.							15
	GLOBUS MEDICAL, INC.							13
	BIO-RAD LABORATORIES, INC.							5
	Average							15
	Weighted average by Cap.							19

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!